Article Text
Commentary
General medicine
Trial supports targeted radiotherapy for early breast cancer but protocol still requires 3 weeks of daily therapy
Statistics from Altmetric.com
Footnotes
Contributors JSV wrote the initial draft. JST and FW made contributions to the draft. All authors approved the final manuscript.
Competing interests Carl Zeiss has sponsored some travel to some conferences and has paid some honoraria.
Provenance and peer review Commissioned; internally peer reviewed.